Literature DB >> 17075121

Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study.

Sang Min Park1, Min Kyung Lim, Soon Ae Shin, Young Ho Yun.   

Abstract

PURPOSE: Although many studies have demonstrated that smoking, alcohol, obesity, and insulin resistance are risk factors for cancer, the role of those factors on cancer survival has been less studied. PATIENTS AND METHODS: The study participants were 14,578 men with a first cancer derived from a cohort of 901,979 male government employees and teachers who participated in a national health examination program in 1996. We obtained mortality data for those years from the Korean Statistical Office. We used a standard Poisson regression model to estimate the hazard ratio (HR) for survival in relation to smoking, alcohol, obesity, and insulin resistance before diagnosis.
RESULTS: Poor survival of all cancer combined (HR, 1.24; 95% CI, 1.16 to 1.33), cancer of the lung (HR, 1.45; 95% CI, 1.15 to 1.82), and cancer of the liver (HR, 1.36; 95% CI, 1.21 to 1.53) were significantly associated with smoking. Compared with the nondrinker, heavy drinkers had worse outcomes for head and neck (HR, 1.85; 95% CI, 1.23 to 2.79) and liver (HR, 1.25; 95% CI, 1.11 to 1.41) cancer, with dose-dependent relationships. Patients with a fasting serum glucose level above 126 mg/dL had a higher mortality rate for stomach (HR, 1.52; 95% CI, 1.25 to 1.84) and lung (HR, 1.48; 95% CI, 1.18 to 1.87) cancer. Higher body mass index was significantly associated with longer survival in head and neck (HR, 0.54; 95% CI, 0.39 to 0.74) and esophagus (HR, 0.44; 95% CI, 0.28 to 0.68) cancer.
CONCLUSION: Prediagnosis risk factors for cancer development (smoking, alcohol consumption, obesity, and insulin resistance) had a statistically significant effect on survival among male cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075121     DOI: 10.1200/JCO.2006.07.0243

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  97 in total

1.  Obesity and head and neck cancer risk and survival by human papillomavirus serology.

Authors:  Xinmiao Tan; Heather H Nelson; Scott M Langevin; Michael McClean; Carmen J Marsit; Tim Waterboer; Michael Pawlita; Karl T Kelsey; Dominique S Michaud
Journal:  Cancer Causes Control       Date:  2014-11-15       Impact factor: 2.506

2.  Disparities in short-term and long-term all-cause mortality among Korean cancer patients with and without preexisting disabilities: a nationwide retrospective cohort study.

Authors:  Sang Min Park; Ki Young Son; Jae-Hyun Park; Belong Cho
Journal:  Support Care Cancer       Date:  2011-04-26       Impact factor: 3.603

3.  Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes.

Authors:  J A Johnson; M Pollak
Journal:  Diabetologia       Date:  2010-07-20       Impact factor: 10.122

4.  Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway.

Authors:  Naifa L Busaidy; Azeez Farooki; Afshin Dowlati; John P Perentesis; Janet E Dancey; Laurence A Doyle; Joanna M Brell; Lillian L Siu
Journal:  J Clin Oncol       Date:  2012-07-09       Impact factor: 44.544

Review 5.  Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis.

Authors:  S Zhong; X Yan; Y Wu; X Zhang; L Chen; J Tang; J Zhao
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-12       Impact factor: 5.554

6.  Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry.

Authors:  Amanda I Phipps; John Baron; Polly A Newcomb
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

7.  Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer.

Authors:  Kuo-Hsing Chen; Yu-Yun Shao; Zhong-Zhe Lin; Yi-Chun Yeh; Wen-Yi Shau; Raymond Nienchen Kuo; Ho-Min Chen; Chiu-Ling Lai; Kun-Huei Yeh; Ann-Lii Cheng; Mei-Shu Lai
Journal:  Oncologist       Date:  2014-07-24

Review 8.  Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.

Authors:  Abby B Siegel; Andrew X Zhu
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

9.  Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?

Authors:  Jeffrey A Johnson; Edwin A M Gale
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

10.  Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea.

Authors:  E H Yun; M K Lim; J-K Oh; J H Park; A Shin; J Sung; E-C Park
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.